Fasting vs non-fasting: assessment of the impact on LIVERSTAT easlfibronostg on June 29, 2026 Category: Publications Tag: Identification, LiverSTAT, MASLD, NAFLD Post navigation Previous: Previous post: LIVERFASt-LFS NIT for Fatty Liver Disease, for Primary Care Provider (PCP) screeningNext: Next post: LIVERSTAT as NIT for risk stratification for MAFLD — a single-centre study using liver biopsy as reference standard (Malaysia)